The Carlson Curve is a term coined by The Economist to describe the biotechnological equivalent of Moore's law, and is named after author Rob Carlson. Carlson predicted that the doubling time of DNA sequencing technologies (measured by cost and performance) would be at least as fast as Moore's law. Carlson Curves illustrate the rapid (in some cases above exponential growth) decreases in cost, and increases in performance, of a variety of technologies, including DNA sequencing, DNA synthesis and a range of physical and computational tools used in protein production and in determining protein structures.
- 454 sequencing (average read length=300-400 bases): 10-fold
- Illumina and SOLiD sequencing (average read length=50-100 bases): 30-fold.
- "Life 2.0.". The Economist. August 31, 2006.
- Robert H. Carlson (April 2011). Biology Is Technology : The Promise, Peril, and New Business of Engineering Life. Cambridge, MA: Harvard University Press.
- Robert Carlson (September 2003). "The Pace and Proliferation of Biological Technologies". Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science. Mary Ann Liebert, Inc. 1 (3: 203-214). doi:10.1089/153871303769201851.
- "DNA Sequencing Costs". National Human Genome Research Institute.
|This genetics article is a stub. You can help Wikipedia by expanding it.|